What’s the Issue?
- Clostridium perfringenes type A overgrowth in the abomasum and/or small intestine.
- Mycotoxicosis (feed sources) in mature cows and inconsistent feeding practices for calves are believed to play a role.
What’s the Impact?
- Results in clinical diseases such as HBS or abomasitis, causing severe disease and high mortality in affected animals.
- Treatment for these diseases may reduce mortality rates but often is ineffective.
- Vaccination for Clostridium per fringes type A has been reported to reduce the incidence of these conditions.
- Only one commercially available Clostridium perfringenes vaccine is currently available; a custom-made bacterin (vaccine) may be a good alternative for herds experiencing problems with these conditions.
- Preventative measures for these conditions include the use of mycotoxin binders, probiotics and vaccination; however all of these products have little research to support their effectiveness.